Search Results for: rent

By Kuldip K. Ambastha and Anil K. Ambastha On Tuesday, February 25, 2020, the stock of Moderna, Inc. (MRNA) rose by 27.8% for the day. As the coronavirus (COVID-19) has spread around the world and led to a sell-off in the capital markets, Moderna, Inc. announced that its coronavirus vaccine candidate is scheduled to be …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 24-28, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha HAPPY HOLIDAYS, EVERYBODY! During this week of Christmas, Peloton Interactive, Inc. (PTON) and WW International, Inc. (formerly Weight Watchers International, Inc.) (WW) caught our eye. On Thursday, December 26, 2019 (the day after Christmas 2019), Peloton dropped by 6.1%, while WW International fell by 8.5%. Peloton is …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 23-27, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On Monday, December 9, 2019, big news emerged in the mergers & acquisitions field in terms of Merck & Co., Inc. (MRK) buying ArQule, Inc. (ARQL) and Sanofi SA (SNY) buying Synthorx Inc. (THOR). Both Merck and Sanofi bought the smaller companies to enhance their capabilities in …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 9-13, 2019”

By Anil K. Ambastha and Kuldip K. Ambastha On September 26, Interactive Brokers (IBKR) announced a new IBKR Lite service effective from October that will feature unlimited, commission-free trades of U.S.-listed stocks and exchange traded funds (ETFs) along with no account minimum or inactivity fee. This news caused only a mild reaction on September 26 …

Continue reading “What Caught Our Attention in the Investment World? – Week of September 30-October 4, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha Acadia Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company which has Nuplazid (aka: pimavanserin) in its product pipeline. Nuplazid has been used by individuals suffering from Parkinson’s disease-linked psychosis. Acadia has now analyzed Nuplazid in relation to individuals suffering from dementia-related psychosis. Currently, no approved drugs exist in …

Continue reading “What Caught Our Attention in the Investment World? – Week of September 9-13, 2019”

By Anil K. Ambastha and Kuldip K. Ambastha Food industry and restaurant industry stocks generally move in a slow and steady manner. Also, once the initial hype is over shortly after an Initial Public Offering (IPO) of a company’s stock, generally, the IPO shares start to decline and, mostly, an IPO’s shares trade for less …

Continue reading “What Caught Our Attention in the Investment World? – Week of July 22-26, 2019”

By Anil K. Ambastha and Kuldip K. Ambastha Second-quarter earnings season started in earnest this week and will continue for the next 3-4 weeks. This week, the S&P 500, Dow 30, and Nasdaq indices respectively dropped by 1.23%, 0.65%, and 1.18%. Thus, movement of the indices was fairly benign and insignificant. However, individual stocks can …

Continue reading “What Caught Our Attention in the Investment World? – Week of July 15-19, 2019”